Skip to main navigation Skip to search Skip to main content

Medications for Anxiety Disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There has been an exponential increase in the number of medications demonstrated to be effective for the treatment of anxiety and anxiety disorders. This chapter provides a brief review of the history and evolution of psychopharmacologic strategies. Data for efficacy and adverse effects of these medications for different anxiety disorders are presented based on clinical trial reports so that the reader can compare and contrast the advantages and disadvantages of different classes of medications for treatment of each anxiety disorder described in the International Classification of Diseases and the Diagnostics and Statistical Manual of Mental Disorders over the past three decades. Specifically, this chapter describes current evidence of medications for anxiety disorders for five disorders: generalized anxiety disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, and obsessive-compulsive disorder. For some drugs, this chapter includes the “Special Populations” sections that show evidence specific to children, adolescents, and elderly patients if available. This chapter also provides a table that summarizes the efficacy of each drug for these five disorders. The other table summarizes pharmacological properties of medications commonly used to treat anxiety disorders. At present, clinicians have a wide array of medications available for the treatment of anxiety and anxiety disorders. The breadth of accessible treatment options greatly facilitates our ability to help patients. Nevertheless, appropriate diagnosis and rapport are still the foundations of any pharmacological intervention that is made with the patients.

Original languageEnglish (US)
Title of host publicationTasman’s psychiatry, Fifth Edition
PublisherSpringer International Publishing
Pages4213-4279
Number of pages67
ISBN (Electronic)9783030513665
ISBN (Print)9783030513658
DOIs
StatePublished - Jan 1 2024

Keywords

  • Benzodiazepine
  • General anxiety disorder
  • MAOI
  • Obsessivecompulsive disorder
  • Panic disorder
  • Posttraumatic stress disorder
  • SNRI
  • SSRI
  • Social anxiety disorder
  • TCA

ASJC Scopus subject areas

  • General Medicine
  • General Psychology
  • General Biochemistry, Genetics and Molecular Biology
  • General Agricultural and Biological Sciences

Fingerprint

Dive into the research topics of 'Medications for Anxiety Disorders'. Together they form a unique fingerprint.

Cite this